Investors

By Dave Muoio 02:43 pm January 21, 2020
Gentem, a San Francisco tech startup looking to streamline reimbursement for smaller practices, has raised $3.7 million in seed funding. Susa Ventures headed the raise, which also saw support from Village Global, Vulcan Capital, Hustle Fund, 500 Fintech, Social Starts, Great Oaks VC and other unnamed backers. WHAT THEY DO In an effort to reduce the stress of payments for those working in small-...
By Laura Lovett 03:11 pm January 20, 2020
Virtual reality-enabled clinical training company Health Scholars has raked in $17 million in Series B funding. This new cash raise comes from investors including Arboretum Ventures, Venture Investors, Capital Midwest Fund, OSF HealthCare and other family office seed funders.  WHAT THEY DO The company uses VR to simulate a variety of clinical situations including operation, resuscitation and...
By Dave Muoio 11:50 am January 20, 2020
Editor's note: A previous version of this story incorrectly placed the raise at $5.1 million. We apologize for this error. Digital gastrointestinal health company Vivante Health has pulled in another $5.8 million, largely from Lifeforce Capital and Big Pi Ventures. NFP Ventures, FCA Venture Partners and Longmont Capital also took part in the Series A1 round. WHAT THEY DO Vivante’s GIThrive is a...
By Dave Muoio 11:31 am January 16, 2020
Bigfoot Biomedical, a diabetes startup looking to automate insulin delivery via a connected insulin pen, has kicked off its Series C round with an initial tranche of $45 million. The raise is headed once again by Abbott, with prior backers Quadrant Capital Advisors, Senvest Capital, Janus Henderson and Cormorant Asset Management pitching in once again. Alongside the news of its raise, Bigfoot...
By Laura Lovett 11:14 am January 16, 2020
Yesterday morning mental health-focused startup Modern Health announced that it scored $31 in Series B funding. Veteran digital health investors Founders Fund and John Doerr led the round, with participation from Kleiner Perkins and Afore Capital.  The company said this latest infusion of cash brings its total capital raise to $42 million.  WHAT THEY DO  The San Francisco-based startup works with...
By Laura Lovett 03:48 pm January 15, 2020
Tech-enabled sleep health startups Fusion Health and Nox Health have announced their plans to merge under the Nox Health name.  Atlanta-based Fusion Health works with payers and employers to deliver sleep treatment programs. Historically, its main focus has been on population sleep health.  Meanwhile, Icelandic company Nox is focused on sleep analytics and diagnostics. The company’s sleep...
By Dave Muoio 03:39 pm January 15, 2020
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, has closed $150 million in aggregate Series B financing. Declaration Partners headed the investments, which also featured Maverick Ventures, AllianceBernstein PCI and SymphonyAI Group. Concerto boasts 90% year-over-year revenue growth for its business, and paired the funding...
By Laura Lovett 04:04 pm January 14, 2020
Digital health funding is on the decline, according to yet another funding report, this time from Mercom Capital Group. According to the company’s latest report, in 2019 digital health funding came in at $8.9 billion with 615 deals — a drop from the $9.5 billion and 698 deals recorded in 2018.  “After three consecutive years of growth, venture deals, and dollars for digital health companies...
By Jonah Comstock 02:58 pm January 14, 2020
Embodied Labs, a young company using virtual reality to provide immersive training for caregivers, has raised $3.2 million in seed funding, the company announced yesterday at the Health 2.0 VentureConnect event on the sidelines of the JP Morgan healthcare conference in San Francisco. “The round is very exciting because we triangulated experts in healthcare and aging care with [experts in]...
By Dave Muoio 02:45 pm January 14, 2020
Following news of hardships at Proteus Digital Health, CEO Andrew Thompson has told STAT News that the company is winding down its high-profile $88 million deal with Otsuka Pharmaceutical, and will be pivoting from its current primary focus on mental disorders toward cancers and infectious disease treatments. The pharmaceutical company has now acquired the full license for Proteus’ mental health...